Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, DexCom (DXCM) has a market cap of $27.15 billion USD. According to our data, DexCom is ranked No.702 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $27.15 B |
-10.96%
|
| Dec 31, 2024 | $30.49 B |
-37.33%
|
| Dec 29, 2023 | $48.66 B |
9.58%
|
| Dec 30, 2022 | $44.40 B |
-15.64%
|
| Dec 31, 2021 | $52.64 B |
45.23%
|
| Dec 31, 2020 | $36.24 B |
69.02%
|
| Dec 31, 2019 | $21.44 B |
82.59%
|
| Dec 31, 2018 | $11.74 B |
108.75%
|
| Dec 29, 2017 | $5.63 B |
-3.87%
|
| Dec 30, 2016 | $5.85 B |
-27.11%
|
| Dec 31, 2015 | $8.03 B |
48.77%
|
| Dec 31, 2014 | $5.40 B |
55.46%
|
| Dec 31, 2013 | $3.47 B |
160.56%
|
| Dec 31, 2012 | $1.33 B |
45.97%
|
| Dec 30, 2011 | $0.91 B |
-31.79%
|
| Dec 31, 2010 | $1.34 B |
69.14%
|
| Dec 31, 2009 | $0.79 B |
192.39%
|
| Dec 31, 2008 | $0.27 B |
-68.74%
|
| Dec 31, 2007 | $0.87 B |
-10.45%
|
| Dec 29, 2006 | $0.97 B |
-33.91%
|
| Dec 30, 2005 | $1.46 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Abbott Laboratories
ABT
|
$228.27 B |
17.338 M
|
USA
|
 Medtronic
MDT
|
$106.96 B |
-0.004 M
|
Ireland
|
 Insulet
PODD
|
$17.75 B |
0.000 M
|
USA
|
 Tandem Diabetes Care
TNDM
|
$1.13 B |
-0.000 M
|
USA
|
 Senseonics Holdings
SENS
|
$0.39 B |
0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$371.78 B |
-0.011 M
|
USA
|
 Eli Lilly
LLY
|
$661.83 B |
0.020 M
|
USA
|
 Novo Nordisk
NVO
|
$283.94 B |
69.324 B
|
Denmark
|
 Sanofi
SNY
|
$128.36 B |
3.704 B
|
France
|
 Becton Dickinson
BDX
|
$58.17 B |
-0.002 M
|
USA
|
| Market Cap | = | DXCM Stock Price | * | DXCM Shares Outstanding |
| = | $69.25 | * | 0.39 B | |
| = | $27.15 B |